H-1B sponsorship profile: Novartis Institutes for BioMedical Research, Inc. Across U.S. Department of Labor LCA disclosures, Novartis Institutes for BioMedical Research, Inc filed 332 Labor Condition Applications covering 332 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 99.7% (331 certified of 332 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Novartis Institutes for BioMedical Research, Inc’s H-1B petitions range from $56,888 at the low end to $239,200 at the high end, with a petition-weighted average of $102,114. That range reflects the mix of occupations the company sponsors, led by Senior Scientist I (64 petitions at $96,136 avg), followed by Senior Scientist II and Principal Scientist I. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Novartis Institutes for BioMedical Research, Inc is headquartered in EAST HANOVER, NJ under NAICS code 54171, and places H-1B workers across 2 states, most heavily in MA, CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.